H.R. 8017, Mobile Options for Testing In Our Neighborhoods Act
Summary
H.R. 8017, the Mobile Options for Testing In Our Neighborhoods Act or the MOTION Act, was introduced in the House of Representatives on August 11, 2020 by Ms. Mucarsel-Powell and referred to the Committee on Energy and Commerce. It directs the Secretary of Health and Human Services, not later than 120 days after enactment, to award grants to establish, improve and maintain mobile testing programs for SARS-CoV-2 and COVID-19. Eligible entities include health centers, State, local, Tribal or territorial health departments and nonprofit organizations, and priority goes to communities with limited access to transportation. It authorizes $400,000,000, to remain available until expended.
Summary drafted by a model from the document's text below and checked by script against that text before publication. It is a navigation aid, not a reading of what the document proves. Where AI is used
- Issuer
- Congressional materials
- Document type
- Bills Bills 116Hr8017Ih Bills 116Hr8017Ih
- Case
- Bills Bills 116Hr8017Ih Bills 116Hr8017Ih
Cite this document
“H.R. 8017, Mobile Options for Testing In Our Neighborhoods Act.”
Original at www.govinfo.gov. Archived at Pandemic Darlings, https://pandemicdarlings.com/source-documents/bills-bills-116hr8017ih-bills-116hr8017ih/
, SHA-256 93c3ab704894010d2b1da3d54408f2ba0a86c147e69f1187e0e0a67909572346.Full text
I
116TH CONGRESS
2D SESSION
H. R. 8017
To direct the Secretary of Health and Human Services to award grants
to eligible entities to establish, improve, and maintain mobile testing
programs for SARS–CoV–2 and COVID–19, and for other purposes.
IN THE HOUSE OF REPRESENTATIVES
AUGUST 11, 2020
Ms. MUCARSEL-POWELL (for herself, Ms. SHERRILL, Mr. HIGGINS of New
York, Mr. COX of California, Mr. LYNCH, Mr. DEUTCH, Ms. ESCOBAR,
Mr. VARGAS, Ms. GARCIA of Texas, Ms. WASSERMAN SCHULTZ, Mr. CLY-
BURN, and Mr. SOTO) introduced the following bill; which was referred
to the Committee on Energy and Commerce
A BILL
To direct the Secretary of Health and Human Services to
award grants to eligible entities to establish, improve,
and maintain mobile testing programs for SARS–CoV–
2 and COVID–19, and for other purposes.
1 Be it enacted by the Senate and House of Representa-
2 tives of the United States of America in Congress assembled,
3 SECTION 1. SHORT TITLE.
4 This Act may be cited as the ‘‘Mobile Options for
5 Testing In Our Neighborhoods Act’’ or the ‘‘MOTION
pamtmann on DSKBC07HB2PROD with BILLS
6 Act’’.
VerDate Sep 11 2014 21:21 Aug 29, 2020 Jkt 099200 PO 00000 Frm 00001 Fmt 6652 Sfmt 6201 E:\BILLS\H8017.IH H8017
2
1 SEC. 2. MOBILE TESTING FOR SARS–COV–2 AND COVID–19.
2 (a) IN GENERAL.—Not later than 120 days after the
3 date of the enactment of this Act, the Secretary of Health
4 and Human Services (in this Act referred to as the ‘‘Sec-
5 retary’’) shall award grants to establish, improve, and
6 maintain mobile testing programs to conduct testing for
7 SARS–CoV–2 and COVID–19.
8 (b) ELIGIBLE ENTITY.—In this section, the term ‘‘el-
9 igible entity’’ means—
10 (1) a health center (as defined in section 330
11 of the Public Health Service Act (42 U.S.C. 3
12 254b)), including community health centers;
13 (2) a federally qualified health center (as de-
14 fined in section 1861 of the Social Security Act (42
15 U.S.C. 1395x));
16 (3) a rural health clinic (as defined in section
17 1861 of the Social Security Act (42 U.S.C. 1395x));
18 (4) a State, local, Tribal, or territorial health
19 department;
20 (5) medical centers and research labs at an in-
21 stitution of higher education (as defined in section
22 101 of the Higher Education Act of 1965 (20
23 U.S.C. 1001));
24 (6) nonprofit organizations; and
pamtmann on DSKBC07HB2PROD with BILLS
25 (7) any other entity as determined by the Sec-
26 retary.
•HR 8017 IH
VerDate Sep 11 2014 21:21 Aug 29, 2020 Jkt 099200 PO 00000 Frm 00002 Fmt 6652 Sfmt 6201 E:\BILLS\H8017.IH H8017
3
1 (c) USE OF FUNDS.—An eligible entity receiving
2 grant funds under subsection (a) shall use the funds to—
3 (1) purchase equipment and supplies to conduct
4 mobile testing for SARS–CoV–2 and COVID–19;
5 (2) serve multiple communities (including zip
6 codes or cities) in a period determined by the Sec-
7 retary;
8 (3) purchase, lease, and maintain mobile vehi-
9 cles and equipment to conduct such testing;
10 (4) hire and train laboratory personnel and
11 other staff to conduct such testing;
12 (5) provide or administer, as the case may be—
13 (A) vaccines licensed under section 351 of
14 the Public Health Service Act (42 U.S.C. 262)
15 for SARS–CoV–2 or COVID–19; and
16 (B) drugs and biological products—
17 (i) approved under sections 505 and
18 564 of the Federal Food, Drug, and Cos-
19 metic Act (21 U.S.C. 355 and 360bbb–3)
20 for SARS–CoV–2 or COVID–19; or
21 (ii) licensed under section 351 of the
22 Public Health Service Act (42 U.S.C. 262)
23 for the cure, mitigation, or treatment of
pamtmann on DSKBC07HB2PROD with BILLS
24 SARS–CoV–2 or COVID–19; and
•HR 8017 IH
VerDate Sep 11 2014 21:21 Aug 29, 2020 Jkt 099200 PO 00000 Frm 00003 Fmt 6652 Sfmt 6201 E:\BILLS\H8017.IH H8017
4
1 (6) carry out other activities related to such
2 testing, as determined by the Secretary.
3 (d) CONSIDERATION.—In establishing the grant pro-
4 gram under subsection (a), the Secretary shall take into
5 consideration COVID–19 testing plans required under the
6 fourth proviso under the second paragraph under the
7 heading ‘‘Department of Health and Human Services—
8 Office of the Secretary—Public Health and Social Serv-
9 ices’’ of title 1 of division B of the Paycheck Protection
10 Program and Health Care Enhancement Act (Public Law
11 116–139).
12 (e) PRIORITY.—In awarding grants pursuant to this
13 section, the Secretary shall give priority to eligible entities
14 that serve—
15 (1) communities that have limited access to
16 transportation, including communities—
17 (A) with a high percentage of households
18 that do not have access to private vehicles;
19 (B) that do not have public transit;
20 (C) with a high percentage of individuals
21 who primarily use public transit for transpor-
22 tation; or
23 (D) with reduced access to public transit
pamtmann on DSKBC07HB2PROD with BILLS
24 as a result of the spread of COVID–19;
•HR 8017 IH
VerDate Sep 11 2014 21:21 Aug 29, 2020 Jkt 099200 PO 00000 Frm 00004 Fmt 6652 Sfmt 6201 E:\BILLS\H8017.IH H8017
5
1 (2) medically underserved populations (as de-
2 fined in section 330(b)(3) of the Public Health Serv-
3 ice Act (42 U.S.C 254b(b)(3))); and
4 (3) health professional shortage areas (as de-
5 fined in section 330(a) of the Public Health Service
6 Act (42 U.S.C 254e(a))).
7 (f) REPORTS.—
8 (1) REPORT TO SECRETARY.—Not later than 1
9 year after the date of the enactment of this Act, an
10 entity that receives grant funds pursuant to this Act
11 shall submit to the Secretary a report on the activi-
12 ties carried out using such grant funds.
13 (2) REPORT TO CONGRESS.—Not later than De-
14 cember 31, 2021, the Secretary shall submit to Con-
15 gress a report on the effectiveness of the activities
16 carried out pursuant to this Act.
17 (g) AUTHORIZATION OF APPROPRIATIONS.—There is
18 authorized to be appropriated to carry out this Act
19 $400,000,000, to remain available until expended.
Æ
pamtmann on DSKBC07HB2PROD with BILLS
•HR 8017 IH
VerDate Sep 11 2014 21:21 Aug 29, 2020 Jkt 099200 PO 00000 Frm 00005 Fmt 6652 Sfmt 6301 E:\BILLS\H8017.IH H8017
File and source
- File
- BILLS_bills-116hr8017ih_bills-116hr8017ih.pdf
- Size
- 234,516 bytes
- SHA-256
- 93c3ab704894010d2b1da3d54408f2ba0a86c147e69f1187e0e0a67909572346
- Original
- www.govinfo.gov